Your session is about to expire
← Back to Search
sleep education program for Sleep
Study Summary
This trial will use evidence-based techniques to improve symptoms of depression, anxiety, and poor sleep in Alzheimer's patients and their caregivers during the COVID-19 pandemic.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the desired outcome of this clinical investigation?
"The primary objective of this clinical trial, the results of which will be assessed immediately after completion of the intervention, is to evaluate Pittsburgh Sleep Quality Index scores. Secondary outcomes are Total scores on Cornell Scale for Depression in Dementia (range 0-38 with higher numbers representing more severe depression symptoms), Patient Health Questionnaire-9 (0-27; increased values signify worse depressive symptoms among caregivers) and Generalized Anxiety Disorder-7 (0-21; greater numerical value indicate greater anxiety levels in caretakers)."
Are applicants still being considered for this investigation?
"Affirmative. Clinicaltrials.gov details that recruitment for this medical trial, which was launched on August 20th 2021, is currently in progress. 15 test subjects are needed at one location to complete the study's objectives."
What is the current participant count in this experiment?
"Indeed, the clinicaltrials.gov database indicates that this experiment is presently recruiting volunteers. It was uploaded on August 20th 2021 with a final update occurring on September 1st 2022 and requires 15 participants from one site in particular."
Share this study with friends
Copy Link
Messenger